GB0620661D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0620661D0
GB0620661D0 GB0620661A GB0620661A GB0620661D0 GB 0620661 D0 GB0620661 D0 GB 0620661D0 GB 0620661 A GB0620661 A GB 0620661A GB 0620661 A GB0620661 A GB 0620661A GB 0620661 D0 GB0620661 D0 GB 0620661D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0620661A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMASOL Ltd
Original Assignee
PHARMASOL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMASOL Ltd filed Critical PHARMASOL Ltd
Priority to GB0620661A priority Critical patent/GB0620661D0/en
Publication of GB0620661D0 publication Critical patent/GB0620661D0/en
Priority claimed from US12/386,507 external-priority patent/US20090270438A1/en
Application status is Ceased legal-status Critical

Links

GB0620661A 2006-10-18 2006-10-18 Novel compounds Ceased GB0620661D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0620661A GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB0620661A GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds
CA 2666581 CA2666581A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
AU2007311621A AU2007311621A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
CNA2007800387417A CN101573116A (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
PCT/GB2007/050639 WO2008047163A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
EP20070824851 EP2081574A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
GB0905120A GB2456434A (en) 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
ZA200902123A ZA200902123B (en) 2006-10-18 2009-03-26 Buprenorphine-containing non-pressurized spray composition for transmucosal administration
IL19790809A IL197908D0 (en) 2006-10-18 2009-04-05 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
US12/386,507 US20090270438A1 (en) 2006-10-18 2009-04-17 Novel compositions and formulations

Publications (1)

Publication Number Publication Date
GB0620661D0 true GB0620661D0 (en) 2006-11-29

Family

ID=37507923

Family Applications (2)

Application Number Title Priority Date Filing Date
GB0620661A Ceased GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds
GB0905120A Withdrawn GB2456434A (en) 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0905120A Withdrawn GB2456434A (en) 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Country Status (8)

Country Link
EP (1) EP2081574A1 (en)
CN (1) CN101573116A (en)
AU (1) AU2007311621A1 (en)
CA (1) CA2666581A1 (en)
GB (2) GB0620661D0 (en)
IL (1) IL197908D0 (en)
WO (1) WO2008047163A1 (en)
ZA (1) ZA200902123B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
ES2577390T3 (en) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Transmucosal administration devices with higher uptake
CA2687979C (en) 2007-05-25 2017-07-04 Tolmar Therapeutics, Inc. Sustained delivery formulations of risperidone compounds
GB2461681A (en) * 2008-04-17 2010-01-13 Pharmasol Ltd Buprenorphine liquid spray formulation with solvent and antioxidant
WO2010072398A2 (en) * 2008-12-22 2010-07-01 Boehringer Ingelheim Limited Veterinary formulations
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
GB2481619B (en) * 2010-06-30 2012-06-20 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
EP2793870A4 (en) * 2011-12-21 2016-02-17 Biodelivery Sciences Int Inc Transmucosal drug delivery devices for use in chronic pain relief
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
EP3368013A4 (en) * 2015-10-27 2019-05-22 Insys Development Company, Inc. Liquid buprenorphine formulations
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1296649A2 (en) * 2000-06-22 2003-04-02 Pharmasol Limited Pharmaceutical compositions comprising an opioid analgesic
EP1392262A1 (en) * 2001-05-24 2004-03-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
JP2006516963A (en) * 2003-02-04 2006-07-13 クリサリス テクノロジーズ インコーポレイテッドChrysalis Technologies Incorporated Aerosol formulations and buspirone, buprenorphine, triazolam, aerosol delivery of cyclobenzaprine and zolpidem
JP2007534387A (en) * 2004-04-23 2007-11-29 フィリップ・モリス・ユーエスエー・インコーポレイテッドPhillip Morris Usa Inc. Aerosol generator and aerosol generation method

Also Published As

Publication number Publication date
CN101573116A (en) 2009-11-04
EP2081574A1 (en) 2009-07-29
GB2456434A (en) 2009-07-22
AU2007311621A1 (en) 2008-04-24
CA2666581A1 (en) 2008-04-24
GB0905120D0 (en) 2009-05-06
ZA200902123B (en) 2010-04-28
IL197908D0 (en) 2009-12-24
WO2008047163A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
TWI461198B (en) Novel compounds
TWI422579B (en) New compounds
TWI386404B (en) Substituted enaminocarbonyl compounds
TWI458725B (en) Substituted enaminocarbonyl compounds
TWI434846B (en) Novel compounds
TWI361067B (en) Novel compounds
EP2089034A4 (en) Novel uses
EP2011788A4 (en) Oxadiazolidinedione compound
GB0710528D0 (en) Novel compounds
ZA200809098B (en) Diarylthiohydantoin compounds
IL199853D0 (en) Novel compounds
GB0608386D0 (en) Compounds
GB0608263D0 (en) Compounds
GB0602424D0 (en) Compounds
GB0625648D0 (en) Compounds
GB0602046D0 (en) Compounds
GB0712888D0 (en) Novel compounds
TWI334353B (en) 4-methylpyridopyrimidinone compounds
GB0704407D0 (en) Compounds
GB0622202D0 (en) Novel compounds
GB0613208D0 (en) Compounds
GB0720444D0 (en) Novel compounds
GB0705882D0 (en) Novel compounds
GB0614070D0 (en) Compounds
GB0611587D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)